Skip to main content
Raul Santos Jr., MD, Cardiology, Grapevine, TX

RaulASantosJr.MD

Cardiology Grapevine, TX

Interventional Cardiology, Nuclear Cardiology, Peripheral Endovascular Interventional Cardiology

Cardiovascular Consultants

Dr. Santos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Santos' full profile

Already have an account?

  • Office

    1600 W College St
    Ste 680
    Grapevine, TX 76051
    Phone+1 817-912-8400
    Fax+1 817-912-8410

Education & Training

  • Texas A&M College of Medicine-Scott and White Medical Center (Temple)
    Texas A&M College of Medicine-Scott and White Medical Center (Temple)Fellowship, Interventional Cardiology, 2005 - 2006
  • Texas A&M College of Medicine-Scott and White Medical Center (Temple)
    Texas A&M College of Medicine-Scott and White Medical Center (Temple)Fellowship, Cardiovascular Disease, 2002 - 2005
  • Cedars-Sinai Medical Center
    Cedars-Sinai Medical CenterResidency, Internal Medicine, 1999 - 2002
  • University of Texas Medical Branch School of Medicine
    University of Texas Medical Branch School of MedicineClass of 1999

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2001 - Present
  • TX State Medical License
    TX State Medical License 2006 - 2025
  • American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

  • D Magazine Best Doctors

Publications & Presentations

PubMed

Journal Articles

  • Intramural Delivery of Recombinant Apolipoprotein A-IMilano/Phospholipid Complex (ETC-216) Inhibits In-Stent Stenosis in Porcine Coronary Arteries  
    Sanjay Kaul, MD; Vladimir Rukshin, MD; Raul Santos, MD; Babak Azarbal, MD; Charles L. Bisgaier, PhD; Jan Johansson, MD; Vivian T. Tsang, BS; Kuang-Yuh Chyu, MD; Bojan ..., Circulation, 5/12/2003

Lectures

  • Long-Term Evolocumab Use in Subjects With Homozygous and Severe Heterozygous Familial Hypercholesterolemia: Primary Results of the TAUSSIG Trial 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • Debate Pro: Coronary Calcium Scoring for Patients With LDL-C 160-189 mg/dL 
    2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019

Press Mentions

  • Long-Term Evolocumab Safe, Effective for Familial Hypercholesterolemia Treatment
    Long-Term Evolocumab Safe, Effective for Familial Hypercholesterolemia TreatmentFebruary 12th, 2020
  • PCSK9 Reassures in Longest-Term Data yet for FH
    PCSK9 Reassures in Longest-Term Data yet for FHFebruary 10th, 2020
  • Eating for Your Heart
    Eating for Your HeartMay 14th, 2018
  • Join now to see all

Professional Memberships

Other Languages

  • Spanish